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Short-Term Mortality in Women Undergoing
Coronary Artery Bypass Surgery (1991 to 2004)
Karin H. Humphries, MBA, DSC,*†‡§ Min Gao, PHD,§ Aihua Pu, MSC,‡ Samuel Lichtenstein, MD,†
Christopher R. Thompson, MD*
Vancouver, British Columbia, Canada
Objectives This study sought to evaluate gender differences and trends in 30-day mortality after coronary artery bypass
surgery (CABG).
Background Evidence for gender differences in short-term mortality after CABG is conflicting. Many studies were from single
centers, included highly selected populations, or had limited clinical information for adequate covariate adjust-
ment. We undertook a population-based analysis using detailed clinical data on all adults undergoing CABG in
the province of British Columbia, Canada.
Methods The study population comprised all residents 20 years and older who underwent isolated CABG between 1991
and 2004. Multiple logistic regression was used to examine the association between gender and 30-day mortal-
ity; time trend analysis was conducted by Mantel-Haenszel chi-square test.
Results The study cohort comprised 20,229 men and 4,983 women. Women were older and had more comorbid condi-
tions than men, but had better ejection fractions and less extensive coronary disease. Thirty-day mortality de-
creased significantly in men (2.4% to 1.9%) and women (5.6% to 1.9%) over the 14-year study period. Overall,
30-day mortality was significantly higher in women (3.6% vs. 2.0%, p  0.001), and adjustment for baseline dif-
ferences did not remove this difference (odds ratio 1.42, 95% confidence interval 1.15 to 1.75). Adjustment for
body surface area, an intrinsic gender difference, further attenuated the relationship (odds ratio 1.26, 95% confi-
dence interval 0.96 to 1.64).
Conclusions The 30-day mortality after CABG decreased significantly between 1991 and 2004, especially in women, suggest-
ing that the gender difference in short-term outcomes is diminishing. The overall 42% higher mortality risk in
women seems to be partially mediated through body surface area, a surrogate for vessel size. (J Am Coll
Cardiol 2007;49:1552–8) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.068(
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wender differences in mortality after coronary artery bypass
urgery (CABG) remain controversial. Resolution of this
ssue is difficult given that a randomized trial for evaluating
ender difference is impossible. Most of the observational
tudies that have examined gender differences in short-term
ortality (in-hospital or 30-day) provide conflicting evi-
ence, with several studies reporting increased mortality in
omen (1–7), whereas others show equivalent outcomes
rom the *Division of Cardiology and †Department of Surgery, University of British
olumbia, Vancouver, British Columbia, Canada; ‡Centre for Health Evaluation and
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umphries is funded by the Michael Smith Foundation and the Canadian Institutes
f Health Research. Supported by a Canadian Institutes of Health Research team
rant in cardiovascular outcomes research and by GENESIS, a Canadian Institutes of
ealth Research–funded interdisciplinary collaboration enhancement team grant.t
Manuscript received April 20, 2006; revised manuscript received August 14, 2006,
ccepted August 21, 2006.8–12). However, the weight of the evidence indicates that
hort-term mortality is higher in women than in men. The
ost recent 2002 data from the Society of Thoracic Sur-
eons National Cardiac Surgery Database reported an
perative mortality of 3.54% in women compared with
.15% in men (7).
See page 1559
There are several possible explanations for the inconsis-
ent findings, including selection or referral bias and inad-
quate adjustment for gender differences in baseline char-
cteristics. Many studies are from single-center tertiary care
ettings, or they include selected patients (e.g., Medicare
atients). Other studies included only minimal information
n patient characteristics, limiting the ability to adjust for
ell-documented differences in baseline characteristics be-ween women and men.
3
t
t
M
P
i
2
t
C
t
c
p
p
e
m
t
o
o
D
i
p
t
S
t
A
w
s
u
3
w
o
i
s
i
d
w
o
t
t
g
g
a
g
r
e
a
t
p
a
o
t
y
S
I
R
T
2
w
3
m
g
o
s
f
s
s
g
d
w
e
B
1553JACC Vol. 49, No. 14, 2007 Humphries et al.
April 10, 2007:1552–8 Improved 30-Day Mortality After CABG in WomenWe therefore undertook a population-based study of
0-day mortality in all adults undergoing isolated CABG in
he province of British Columbia using detailed, prospec-
ively collected demographic, clinical, and procedural data.
ethods
opulation and data sources. All patients undergoing
solated CABG in British Columbia between 1991 and
004 were eligible for the study. Patients were excluded if
hey were less than 20 years old or if they were not British
olumbia residents. The study cohort was identified from
he British Columbia Cardiac Registry, which prospectively
aptures information on all invasive cardiac procedures
erformed in British Columbia. All CABG procedures are
erformed at 4 tertiary care centers. Dedicated personnel
nter detailed demographic, procedural, and clinical infor-
ation on each patient into the Registry database. Fewer
han 3% of British Columbia patients undergo CABG
utside the province. Deaths within 30 days of surgery were
btained from the British Columbia Vital Statistics Agency
eath Registry through probabilistic linkage using patient
dentifying information, including each patient’s unique
ersonal health number. Based on previous work, we know
hat data linkage between the British Columbia Vital
tatistics Agency and the British Columbia Cardiac Regis-
ry identifies between 95.7% and 99.8% of deaths (13).
nalyses. Gender differences in baseline characteristics
ere first examined univariately using Student t and chi-
quare tests, as appropriate. Multiple logistic regression was
sed to examine the relationship between gender and
0-day mortality adjusting for various covariates. Covariates
ere selected based on clinical relevance and the significance
f univariate associations (p  0.2). All variables were kept
n the model if they were clinically relevant or statistically
ignificant (p  0.05). Covariates that were examined
ncluded gender, age, year of surgery, acute coronary syn-
rome (unstable angina/acute myocardial infarction 6
eeks), prior cardiac surgery, diabetes, heart failure, chronic
bstructive pulmonary disease, stroke, renal disease, sys-
emic hypertension, pulmonary hypertension, urgency sta-
us, ejection fraction, Canadian Cardiovascular Society an-
ina class, number of diseased vessels, number of bypass
rafts, cross-clamp time, arterial graft use, and body surface
rea (BSA). We also evaluated interactions between
ender and age, and gender and BSA. The differential
ate of decline in mortality between the genders was
xamined by evaluating the interaction between gender
nd surgical years, a test for difference of the linear year
rend between genders. Gender differences over time in
atient conditions and surgical technique were also ex-
mined by logistic regression. The univariate assessment
f time trend on 30-day mortality was conducted using
he Mantel-Haenszel chi-square test. All statistical anal-
ses were performed using the statistical analysis software
*AS (version 9.1, SAS Institute
nc., Cary, North Carolina).
esults
he study cohort comprised
0,229 men and 4,983 (19.8%)
omen. Women were on average
years older than men, and were
ore likely to present for emer-
ency surgery and with acute cor-
nary syndrome. Compared with men, women had less exten-
ive coronary disease and better-preserved left ventricular
unction, as assessed by ejection fraction. The prevalence of
troke, heart failure, systemic hypertension, and diabetes was
ignificantly higher in women than in men. The use of arterial
rafts was lower in women irrespective of the extent of vessel
isease (Table 1).
Overall 30-day mortality was 2.0% in men and 3.6% in
omen (p  0.001). At all ages, mortality in women
xceeded that in men (Fig. 1) and the greatest difference was
aseline Characteristics by Gender
Table 1 Baseline Characteristics by Gender
Characteristic
Men
(n  20,229)
Women
(n  4,983) p Value
Age (mean  SD, yrs) 64.2 9.7 67.1 9.2 0.01
Body surface area
(mean  SD, m2)
2.0 0.2 1.8 0.2 0.01
Body mass index (mean  SD,
kg/m2)
27.9 4.4 27.9 5.4 0.90
Extent of coronary disease (%) 0.01
1- or 2-vessel disease 15.6 19.9
3-vessel disease 61.0 57.1
Left main disease 23.4 23.0
Ejection fraction (%) 0.01
35 10.8 8.2
35–50 33.8 30.9
50 55.4 61.0
Emergency (%) 3.3 4.6 0.01
Overall arterial grafts used* (%) 80.0 66.9 0.01
Arterial grafts used by extent of
disease* (%)
1- or 2-vessel disease 78.7 68.0 0.01
3-vessel disease 80.3 66.3 0.01
Left main disease 80.5 67.6 0.01
Off-pump surgery (%) 3.0 3.5 0.11
Acute coronary syndrome 53.9 63.0 0.01
CCS angina class III or IV (%) 84.3 90.6 0.01
Prior cardiac surgery (%) 8.7 6.7 0.01
Stroke (%) 7.6 9.3 0.01
Heart failure (%) 9.6 12.7 0.01
Diabetes mellitus (%) 21.5 27.5 0.01
Peripheral vascular disease (%) 11.4 13.3 0.01
Renal dysfunction† (%) 11.3 10.6 0.19
Systemic hypertension (%) 42.9 52.0 0.01
Pulmonary hypertension (%) 3.4 4.1 0.01
Cross-clamp time 1 h (%) 68.0 61.1 0.01
Abbreviations
and Acronyms
BSA  body surface area
CABG  coronary artery
bypass grafting
CI  confidence interval
OR  odds ratio
RR  risk ratioUse of at least one arterial graft. †Serum creatinine 20
CCS  Canadian Cardiovascular Society.0 mol/l or on dialysis.
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Improved 30-Day Mortality After CABG in Women April 10, 2007:1552–8bserved in the 50-years-old age group (odds ratio [OR]
.51, 95% confidence interval [CI] 0.89 to 7.09). However,
he interaction between gender and age was not statistically
ignificant (p 0.74). Over the 14-year period of the study,
0-day mortality decreased significantly, from 3.1% overall
o 1.9% (p 0.001 for trend). The magnitude of the decline
mong women was the most striking, falling from 5.6% in
991 to 1.9% in 2004 (Fig. 2).
In the univariate analysis of gender and 30-day mortality,
omen were 85% more likely to die than men (OR 1.85,
5% CI 1.55 to 2.22). We then developed models in
ierarchical order, which we further adjusted for: 1) age, 2)
Figure 1 Post-CABG 30-Day Mortality (%)
by Gender and Age Group
The odds ratios (OR) shown are the unadjusted ORs for post-coronary
artery bypass graft (CABG) 30-day mortality in women compared with men.
*p  0.05.
Figure 2 Time Trend for Post-CABG
30-Day Mortality Rate by Gender
CABG  coronary artery bypass graft.tomorbid conditions, 3) surgical factors and surgical year,
nd 4) BSA (Table 2). The comorbid conditions included
cute coronary syndrome, heart failure, diabetes, stroke,
enal disease, pulmonary hypertension, prior cardiac surgery,
jection fraction, urgency status, and number of diseased
essels. The surgical factors included cross-clamp time, off
ump indicator, and number of bypasses and arterial graft
sed. As shown in Table 2, even after adjustment for age,
omorbid conditions, and surgical factors, women were still
t increased risk compared with men (OR 1.42, 95% CI
.15 to 1.75). However, after further adjustment for BSA
he gender difference was no longer statistically significant.
n summary, age adjustment alone accounted for a 21%
eduction in risk. Surgical factors and surgical year contrib-
ted an additional 24% risk reduction after adjusting for age
nd comorbid conditions, whereas the addition of BSA
esulted in a further risk reduction of 16%. The odds ratio
lot for the adjusted model without BSA, model #4 in Table
, is shown in Figure 3.
The adjusted odds ratio for 30-day mortality by year for
omen versus men (Fig. 4) illustrates the decline in gender
ifferences after adjustment with model #4. Although year
f surgery was significantly associated with 30-day mortality
Fig. 3), the test for interaction between gender and year of
urgery did not reach statistical significance (p  0.16).
We also examined BSA, considered a surrogate for vessel
ize. Small BSA was univariately associated with higher
0-day mortality overall and also when stratified by gender
Fig. 5). However, the association no longer was statistically
ignificance after adjustment for gender and comorbidities, nor
as there an interaction between gender and BSA on 30-day
ortality (p 0.67). Nevertheless, when BSA was forced into
he adjusted model, it attenuated the association between
ender and 30-day mortality (OR 1.26, 95% CI 0.96 to 1.64).
To determine whether there were any significant differ-
ntial changes over time that might explain the steeper
ecline in mortality in women, we examined several factors
or gender differences by surgical year. As shown in Table 3,
he gender difference in comorbid conditions did not change
ver the 14-year time frame, with the exception of BSA,
rior cardiac surgery, and renal disease. The gender differ-
nce in the number of bypass grafts also did not change over
ffect of Covariate Adjustments on thessociation Betw en Gender and 30-Day Mortality
Table 2 Effect of Covariate Adjustments on theAssociation Between Gender and 30-Day Mortality
Model # Covariates Odds Ratio
95% Confidence
Interval
1 Gender 1.85 1.55–2.22
2 Model 1  age 1.64 1.37–1.96
3 Model 2  comorbid conditions* 1.66 1.35–2.02
4 Model 3  surgical year 
surgical factors†
1.42 1.15–1.75
5 Model 4  body surface area 1.26 0.96–1.64
Comorbid conditions were acute coronary syndrome, heart failure, renal disease, diabetes, stroke,
jection fraction, pulmonary hypertension, prior surgery, and urgency status. †Surgical factors were
ross-clamp time, off pump (yes/no), arterial graft used (yes/no), and number of bypass grafts.ime (p for interaction 0.31), with women receiving fewer
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April 10, 2007:1552–8 Improved 30-Day Mortality After CABG in Womenrafts irrespective of extent of coronary disease (Fig. 6).
owever, the gender difference in use of arterial grafts
hanged significantly over time, showing that although
omen were consistently less likely to receive an arterial
raft compared with men, the rate of increase in the use of
rterial grafts was greater in women than in men over time
Figure 3 Odds Ratio Plot for 30-Day Mortality (Model #4)
Urgency status levels: Priority I, within 72 h; II, within 6 weeks; III, within 3 month
ejection fraction 35%, urgency status Priority II and III, cross (X)-clamp time 1 h
Figure 4 Adjusted Odds Ratios (Women Vs. Men)
for 30-Day Mortality by Surgical Year
Odds ratios (women vs. men) and 95% confidence intervals for 30-day mortality
are adjusted for age, acute coronary syndrome, heart failure, renal disease,
diabetes, stroke, ejection fraction, pulmonary hypertension, prior surgery,
urgency status, cross-clamp time, off pump (yes/no), arterial graft used, and
number of bypass grafts.Table 3). Of note, the lower use of arterial grafts in women
as independent of the number of diseased vessels (Table 1).
iscussion
n a population-based study of all adults undergoing isolated
ABG in the province of British Columbia, 30-day mor-
ality improved significantly between 1991 and 2004, de-
rence levels: age 50 years old, 1-vessel or 2-vessel disease,
ical years 1991/1992. ACS  acute coronary syndrome; HTN  hypertension.
Figure 5 Association Between BSA
(in Quintiles) and Mortality by Gender
BSA (m2)  ([Height (cm) · Weight (kg)]/3,600)1/2.
BSA  body surface area; CABG  coronary artery bypass graft.s. Refe
, surg
c
w
d
o
H
n
i
s
1
d
c
i
r
f
s
h
b
o
b
s
w
i
p
c
c
o
and
er
D
is
tr
ib
ut
io
n
an
d
W
om
en
V
er
su
s
M
en
O
dd
s
R
at
io
s
of
P
re
se
nt
in
g
W
it
h
S
el
ec
te
d
B
as
el
in
e
C
on
di
ti
on
s
O
ve
r
Ti
m
e
ab
le
3
G
en
de
r
D
is
tr
ib
ut
io
n
an
d
W
om
en
V
er
su
s
M
en
O
dd
s
R
at
io
s
of
P
re
se
nt
in
g
W
it
h
S
el
ec
te
d
B
as
el
in
e
C
on
di
ti
on
s
O
ve
r
Ti
m
e
C
on
di
ti
on
1
9
9
1
–1
9
9
2
1
9
9
3
–1
9
9
4
1
9
9
5
–1
9
9
6
1
9
9
7
–1
9
9
8
1
9
9
9
–2
0
0
0
2
0
0
1
–2
0
0
2
2
0
0
3
–2
0
0
4
p
V
al
ue
om
en
(%
)
2
0
.7
8
2
0
.2
8
2
0
.9
1
2
0
.5
7
1
9
.1
7
1
8
.5
7
1
8
.4
9

0
.0
0
1
O
dd
s
R
at
io
s
of
S
el
ec
te
d
C
on
di
ti
on
s
(W
om
en
vs
.
M
en
)
ge

7
5
yr
s
1
.4
4
(1
.1
2
–1
.8
5
)
1
.8
9
(1
.5
0
–2
.3
8
)
1
.8
4
(1
.5
0
–2
.2
6
)
1
.5
5
(1
.2
7
–1
.8
8
)
1
.7
1
(1
.4
1
–2
.0
7
)
1
.5
6
(1
.2
8
–1
.9
0
)
1
.9
6
(1
.6
3
–2
.3
5
)
0
.3
9
od
y
su
rf
ac
e
ar
ea

1
.7
5
m
2
1
0
.2
3
(8
.1
0
–1
2
.9
1
)
1
2
.1
4
(9
.6
5
–1
5
.2
6
)
1
3
.8
2
(1
1
.1
5
–1
7
.1
3
)
9
.7
4
(7
.9
8
–1
1
.8
9
)
1
0
.1
5
(8
.3
2
–1
2
.3
8
)
9
.6
(7
.8
3
–1
1
.7
7
)
9
.1
4
(7
.5
6
–1
1
.0
6
)
0
.0
3
m
er
ge
nc
y
1
.2
8
(0
.8
4
–1
.9
5
)
1
.4
4
(0
.9
9
–2
.0
9
)
1
.3
2
(0
.9
0
–1
.9
4
)
1
.8
(1
.2
5
–2
.5
8
)
1
.4
(0
.8
8
–2
.2
3
)
1
.0
8
(0
.6
7
–1
.7
4
)
1
.3
3
(0
.8
8
–2
.0
2
)
0
.7
7
-v
es
se
ld
is
ea
se
0
.7
3
(0
.5
9
–0
.8
9
)
0
.9
1
(0
.7
3
–1
.1
5
)
0
.8
2
(0
.6
6
–1
.0
2
)
0
.6
1
(0
.5
0
–0
.7
5
)
0
.6
7
(0
.5
5
–0
.8
2
)
0
.6
7
(0
.5
4
–0
.8
3
)
0
.9
1
(0
.7
3
–1
.1
4
)
0
.8
6
je
ct
io
n
fr
ac
tio
n

3
5
%
0
.9
(0
.6
5
–1
.2
4
)
0
.6
9
(0
.5
0
–0
.9
7
)
0
.7
4
(0
.5
5
–1
.0
0
)
0
.7
5
(0
.5
6
–0
.9
9
)
0
.6
3
(0
.4
7
–0
.8
6
)
0
.7
5
(0
.5
5
–1
.0
2
)
0
.7
4
(0
.5
5
–1
.0
0
)
0
.5
2
ny
ar
te
ri
al
gr
af
t
us
ed
0
.4
4
(0
.3
7
–0
.5
3
)
0
.4
2
(0
.3
5
–0
.5
0
)
0
.4
9
(0
.4
2
–0
.5
9
)
0
.5
5
(0
.4
6
–0
.6
6
)
0
.5
8
(0
.4
9
–0
.7
0
)
0
.5
3
(0
.4
3
–0
.6
6
)
0
.5
5
(0
.4
4
–0
.6
9
)

0
.0
1
ro
ss
-c
la
m
p
tim
e

1
h
0
.7
5
(0
.6
3
–0
.9
0
)
0
.7
5
(0
.6
2
–0
.9
0
)
0
.8
(0
.6
7
–0
.9
5
)
0
.6
7
(0
.5
7
–0
.7
9
)
0
.7
5
(0
.6
3
–0
.8
8
)
0
.7
(0
.5
8
–0
.8
5
)
0
.7
8
(0
.6
5
–0
.9
3
)
0
.8
0
cu
te
co
ro
na
ry
sy
nd
ro
m
e
1
.4
6
(1
.2
3
–1
.7
4
)
1
.7
8
(1
.4
8
–2
.1
4
)
1
.4
4
(1
.2
1
–1
.7
1
)
1
.2
5
(1
.0
6
–1
.4
6
)
1
.4
3
(1
.2
1
–1
.6
8
)
1
.4
2
(1
.2
0
–1
.6
9
)
1
.4
9
(1
.2
7
–1
.7
6
)
0
.5
0
ri
or
su
rg
er
y
0
.6
(0
.4
3
–0
.8
2
)
0
.5
6
(0
.3
9
–0
.8
0
)
0
.7
4
(0
.5
3
–1
.0
2
)
0
.8
7
(0
.6
6
–1
.1
7
)
0
.7
8
(0
.5
7
–1
.0
8
)
0
.8
(0
.5
6
–1
.1
5
)
0
.9
2
(0
.6
4
–1
.3
1
)
0
.0
2
ea
rt
fa
ilu
re
1
.9
4
(1
.4
4
–2
.6
1
)
1
.4
5
(1
.0
8
–1
.9
5
)
1
.0
4
(0
.7
7
–1
.4
0
)
1
.3
(1
.0
0
–1
.6
9
)
1
.3
8
(1
.0
9
–1
.7
5
)
1
.4
3
(1
.1
4
–1
.8
0
)
1
.4
3
(1
.1
5
–1
.8
0
)
0
.5
9
en
al
di
se
as
e
0
.9
5
(0
.7
0
–1
.3
)
0
.9
1
(0
.6
5
–1
.2
8
)
1
.3
5
(1
.0
0
–1
.8
2
)
1
.3
9
(1
.0
5
–1
.8
5
)
0
.9
1
(0
.7
1
–1
.1
7
)
0
.8
3
(0
.6
5
–1
.0
4
)
0
.8
(0
.6
4
–1
.0
1
)
0
.0
3
ia
be
te
s
m
el
lit
us
1
.6
1
(1
.2
8
–2
.0
3
)
1
.4
4
(1
.1
5
–1
.8
0
)
1
.4
3
(1
.1
6
–1
.7
6
)
1
.3
7
(1
.1
4
–1
.6
4
)
1
.5
6
(1
.3
2
–1
.8
6
)
1
.4
2
(1
.1
9
–1
.7
0
)
1
.2
7
(1
.0
8
–1
.5
1
)
0
.2
6
tr
ok
e
1
.6
3
(1
.1
9
–2
.2
4
)
1
.2
5
(0
.9
0
–1
.7
4
)
1
.4
(1
.0
7
–1
.8
5
)
1
.1
8
(0
.9
2
–1
.5
2
)
1
.1
8
(0
.8
8
–1
.5
7
)
1
.0
1
(0
.7
4
–1
.3
9
)
1
.2
7
(0
.9
5
–1
.7
0
)
0
.1
5
ul
m
on
ar
y
hy
pe
rt
en
si
on
1
.8
5
(1
.0
4
–3
.2
7
)
1
.1
1
(0
.6
2
–1
.9
8
)
0
.7
8
(0
.4
4
–1
.3
6
)
1
.3
1
(0
.8
5
–2
.0
3
)
1
.1
2
(0
.7
8
–1
.6
0
)
1
.5
4
(1
.0
8
–2
.2
0
)
1
.2
8
(0
.8
9
–1
.8
2
)
0
.7
1
1556 Humphries et al. JACC Vol. 49, No. 14, 2007
Improved 30-Day Mortality After CABG in Women April 10, 2007:1552–8lining from 3.1% to 1.9% (p 0.001). The mortality rate in
omen decreased from 5.6% to 1.9% over this time period, but
espite this improvement, women were 42% more likely
verall to die within 30 days of CABG compared with men.
owever, after adjustment for BSA, the gender difference was
o longer significant (OR 1.26, 95% CI 0.96 to 1.64).
The decline in mortality overall, but especially in women,
s noteworthy. The Northern New England group reported
imilar results after reviewing their data between 1987 and
997. In the New England study cohort, the absolute
ecline in the adjusted mortality rate was 3.1% in women
ompared with 1.5% in men (14). A recent review of CABG
n 8 Canadian provinces, using administrative data, also
eported significant declines in overall operative mortality,
rom 3.1% in 1992/1993 to 2.1% in 2000/2001 (2). This
tudy also reported that female gender was associated with a
igher risk of in-hospital mortality compared with men
etween 1992/1993 and 2000/2001, even after adjustment
f differences in baseline characteristics.
The observed decline in mortality is unlikely to be caused
y temporal changes in either the type of patient undergoing
urgery or changes in the distribution of risk factors between
omen and men. Although there was a statistically signif-
cant change in the OR (women vs. men) for renal disease,
rior cardiac surgery, and BSA 1.75, it is important to
onsider the direction and magnitude of those changes. The
hanges in renal disease are inconsistent—lower female
dds ratio in the earliest period and the latest period—and
re thus difficult to interpret. The increase in the female
Figure 6 Gender Difference in the Number of Bypass Grafts
Used Relative to the Number of Diseased Vessels
Proportions of women and men receiving the specified number
of grafts (range 1 to 8) stratified by the extent of coronary disease.odds ratio for prior cardiac surgery would have increased theGe T W A B E 3 E A C A P H R D S P
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April 10, 2007:1552–8 Improved 30-Day Mortality After CABG in Womenisk of mortality, whereas the decrease in the female odds
atio for BSA 1.75 would favor improved outcome.
owever, the magnitude of the change in BSA is unlikely to
xplain the significant decline in mortality that was ob-
erved. A possible contributor to the reduction in women’s
ortality is the increased use of arterial grafts in women
ver time.
The reasons for the steeper decline in mortality in women
emain speculative, but may include improvements in the
echnique of coronary anastomosis, which would be of
articular benefit in patients with small coronary vessels, as
ell as refinement of perioperative management, which
ould be expected to provide the greatest benefit to those at
ighest risk.
Our results with respect to gender differences in 30-day
ortality are consistent with those of most studies, which
ound higher short-term mortality in women (1–7). An-
ther interesting finding was the 2.5-fold higher mortality
n women50 years old compared with men50 years old.
lthough this did not reach statistical significance, possibly
ecause of the small number of subjects in this age group, it
s consistent with the results from Vaccarino et al. (1), in
hich women50 years old were 3 times more likely to die
n the hospital than men. But our study differs from that of
accarino et al. (1) because their study included CABG and
alve surgery patients, whereas ours included only isolated
ABG patients. We examined the characteristics of women
50 years old and found a greater burden of several
omorbidities relative to men 50 years old. Younger
omen had significantly higher prevalence of diabetes, prior
yocardial infarction/unstable angina, heart failure, and
hronic obstructive pulmonary disease compared with the
ounger men. These women were also more likely than their
ale counterparts to undergo emergency surgery, but less
ikely to receive an arterial graft. Younger women hospital-
zed with myocardial infarction have also been shown to
ave higher in-hospital mortality than younger men (1),
uggesting that younger women with coronary artery disease
ay represent a particularly high-risk group.
In the studies that reported no gender differences in
utcome, crude rates were higher in women (8–11), but
fter adjustment for baseline differences, the relative risk
ropped from 2- to 1.3-fold and was no longer significantly
ifferent from that in men. This is in contrast to our results,
n which the gender difference remained significant despite
xtensive adjustment for baseline differences, including ejec-
ion fraction, cross-clamp time, use of an arterial graft,
urgical year, and number of bypass grafts. Koch et al. (8)
erformed a propensity-matched analysis in 15,597 patients
ho underwent isolated CABG and found no gender
ifferences in outcome. It is, however, important to note
hat 74% of women in that cohort were excluded because
hey could not be matched, limiting the generalizability of
hat result.
The importance of BSA, a surrogate for vessel size, on
utcomes remains controversial, and the relationship be- fween gender, body size, and coronary vessel diameter is
learly complex. Gender differences in outcomes have been
ttributed to small vessel size in women (4,15), and small
ody size has been shown to be associated with increased
perative mortality in some (5,9) but not all studies (16).
ickleborough et al. (17) measured the prevalence of small
oronary arteries in men and women undergoing CABG
nd showed that the proportion of women with small (1.5
m) coronary arteries (57%) was no different than the
roportion of men with small coronary arteries (59%). In
ontrast, the New England Cardiovascular Disease Study
roup reported that even after normalizing for BSA,
omen had smaller mid–left atrial dimension diameters
han men (14). Similar findings were reported by Sheifer et
l. (18) using intravascular ultrasound to measure arterial
nd luminal diameters, suggesting that BSA may not
dequately reflect coronary artery size.
In the study by Hammar et al. (11), adjustment for age
nd BSA reduced the relative risk (RR) of mortality
ttributable to gender from 1.8 (95% CI 1.0 to 3.0) to 1.0
95% CI 0.5 to 2.0). In the analysis by Woods et al. (12),
ven after adjustment with 17 clinical variables, the RR
ssociated with female gender was 1.97 (95% CI 1.21 to
.19), but with the addition of BSA the RR decreased to a
onsignificant 1.32 (95% CI 0.73 to 2.37). In our study,
djustment for comorbid conditions had little effect on the
ssociation, but surgical factors were strong modifiers, even
fter adjustment for number of diseased vessels and comor-
id conditions. The lower number of bypass grafts and the
ower use of arterial grafts in women compared with men for
he same extent of coronary disease suggests incomplete
evascularization in women, which likely impacts both
hort-term and long-term mortality (19,20).
There are several limitations of this study. Despite the
vailability of comprehensive clinical information on all
atients who underwent CABG, we cannot exclude the
ossibility that there is residual confounding from unmea-
ured factors. Among these potential confounders are so-
ioeconomic status and psychosocial profile (21,22), which
re known to be differentially distributed by gender and
trongly associated with outcome. The failure to show a
tatistically significant interaction between gender and sur-
ical year on 30-day mortality, despite the impressive
mprovement in outcomes in women over the 14-year study,
s likely attributable to the sample size, specifically the small
umber of women.
Despite these potential limitations, this study has several
trengths. By using all patients undergoing CABG within
ne province, we have reduced selection bias, but not
eferral bias, as this relates to who is referred for CABG.
nother strength is the 14 years of extensive, prospectively
ollected clinical information and our ability to reliably
apture all deaths, both in and out of hospital, making our
ollow-up more complete and less selective.
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n this large, population-based study, we have shown a
igher probability of 30-day mortality in women compared
ith men after isolated CABG. Adjustment for BSA, an
ntrinsic gender difference, attenuated the difference in
utcome, suggesting that coronary vessel size partially me-
iates the relationship between gender and outcome. The
esults of this study also show a significant improvement in
verall mortality between 1991 and 2004, with a substantial
mprovement in women and a consequent narrowing of the
ap in outcomes between women and men. Although the
mprovement in 30-day mortality in women was not statis-
ically different from the improvement in men, a decline
rom 5.6% to 1.9% is clinically important. Confirmation
hat the gender difference in outcomes is diminishing
hould be verified in other contemporary cohorts.
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